Notch Signaling Regulates Antigen Sensitivity of Naive CD4+ T Cells by Tuning Co-stimulation

Immunity

Volumn 42, Issue 1, 2015, Pages 80-94

  Laky, Karen ^a   Evans, Sharron ^a   Perez Diez, Ainhoa ^a   Fowlkes, B J ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; CD28 ANTIGEN; CYTOKINE; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE PROTEIN; PEPTIDE FRAGMENT; PROTEIN; SIGNAL PEPTIDE; TUMOR ANTIGEN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL METABOLISM; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; EFFECTOR CELL; FEMALE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNOLOGY; ANIMAL; C57BL MOUSE; CANCER TRANSPLANTATION; CARCINOMA; CELL CULTURE; CELL PROLIFERATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; TRANSGENIC MOUSE; TUMOR VOLUME;

ANIMALS; ANTIGENS, CD28; ANTIGENS, NEOPLASM; CARCINOMA; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; FEMALE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NEOPLASM TRANSPLANTATION; PEPTIDE FRAGMENTS; RECEPTOR CROSS-TALK; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TUMOR BURDEN;

EID: 84921315205     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2014.12.027     Document Type: Article

References (57)

1. Adler S.H., Chiffoleau E., Xu L., Dalton N.M., Burg J.M., Wells A.D., Wolfe M.S., Turka L.A., Pear W.S. Notch signaling augments Tcell responsiveness by enhancing CD25 expression. J.Immunol. 2003, 171:2896-2903.
2. Amsen D., Antov A., Jankovic D., Sher A., Radtke F., Souabni A., Busslinger M., McCright B., Gridley T., Flavell R.A. Direct regulation of Gata3 expression determines the T helper differentiation potential of Notch. Immunity 2007, 27:89-99.
3. Auderset F., Schuster S., Fasnacht N., Coutaz M., Charmoy M., Koch U., Favre S., Wilson A., Trottein F., Alexander J., et al. Notch signaling regulates follicular helper Tcell differentiation. J.Immunol. 2013, 191:2344-2350.
4. Bayer A.L., Baliga P., Woodward J.E. Transferrin receptor in Tcell activation and transplantation. J.Leukoc. Biol. 1998, 64:19-24.
5. Brekelmans P., van Soest P., Leenen P.J.M., van Ewijk W. Inhibition of proliferation and differentiation during early Tcell development by anti-transferrin receptor antibody. Eur. J. Immunol. 1994, 24:2896-2902.
6. Brekelmans P., van Soest P., Voerman J., Platenburg P.P., Leenen P.J.M., van Ewijk W. Transferrin receptor expression as a marker of immature cycling thymocytes in the mouse. Cell. Immunol. 1994, 159:331-339.
7. Chan S.M., Weng A.P., Tibshirani R., Aster J.C., Utz P.J. Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia. Blood 2007, 110:278-286.
8. Chen L., Flies D.B. Molecular mechanisms of Tcell co-stimulation and co-inhibition. Nat. Rev. Immunol. 2013, 13:227-242.
9. Cheng P., Zhou J., Gabrilovich D. Regulation of dendritic cell differentiation and function by Notch and Wnt pathways. Immunol. Rev. 2010, 234:105-119.
10. Ciofani M., Zúñiga-Pflücker J.C. Notch promotes survival of pre-T cells at the β-selection checkpoint by regulating cellular metabolism. Nat. Immunol. 2005, 6:881-888.
11. Cotner T., Williams J.M., Christenson L., Shapiro H.M., Strom T.B., Strominger J. Simultaneous flow cytometric analysis of human Tcell activation antigen expression and DNA content. J.Exp. Med. 1983, 157:461-472.
12. Dongre A., Surampudi L., Lawlor R.G., Fauq A.H., Miele L., Golde T.E., Minter L.M., Osborne B.A. Non-canonical Notch signaling drives activation and differentiation of peripheral CD4+ Tcells. Front. Immunol. 2014, 5:54.
13. Edinger A.L. Controlling cell growth and survival through regulated nutrient transporter expression. Biochem. J. 2007, 406:1-12.
14. Fischer A., Gessler M. Delta-Notch-and then? Protein interactions and proposed modes of repression by Hes and Hey bHLH factors. Nucleic Acids Res. 2007, 35:4583-4596.
15. Frauwirth K.A., Riley J.L., Harris M.H., Parry R.V., Rathmell J.C., Plas D.R., Elstrom R.L., June C.H., Thompson C.B. The CD28 signaling pathway regulates glucose metabolism. Immunity 2002, 16:769-777.
16. Helbig C., Gentek R., Backer R.A., de Souza Y., Derks I.A., Eldering E., Wagner K., Jankovic D., Gridley T., Moerland P.D., et al. Notch controls the magnitude of T helper cell responses by promoting cellular longevity. Proc. Natl. Acad. Sci. USA 2012, 109:9041-9046.
17. Inaba K., Steinman R.M. Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine release. J.Exp. Med. 1984, 160:1717-1735.
18. Ishida W., Fukuda K., Sakamoto S., Koyama N., Koyanagi A., Yagita H., Fukushima A. Regulation of experimental autoimmune uveoretinitis by anti-delta-like ligand 4 monoclonal antibody. Invest. Ophthalmol. Vis. Sci. 2011, 52:8224-8230.
19. Itoh Y., Germain R.N. Single cell analysis reveals regulated hierarchical Tcell antigen receptor signaling thresholds and intraclonal heterogeneity for individual cytokine responses of CD4+ Tcells. J.Exp. Med. 1997, 186:757-766.
20. Jacobs S.R., Herman C.E., Maciver N.J., Wofford J.A., Wieman H.L., Hammen J.J., Rathmell J.C. Glucose uptake is limiting in Tcell activation and requires CD28-mediated Akt-dependent and independent pathways. J.Immunol. 2008, 180:4476-4486.
21. Jehn B.M., Bielke W., Pear W.S., Osborne B.A. Cutting edge: protective effects of notch-1 on TCR-induced apoptosis. J.Immunol. 1999, 162:635-638.
22. Jelley-Gibbs D.M., Strutt T.M., McKinstry K.K., Swain S.L. Influencing the fates of CD4 Tcells on the path to memory: lessons from influenza. Immunol. Cell Biol. 2008, 86:343-352.
23. Keerthivasan S., Suleiman R., Lawlor R., Roderick J., Bates T., Minter L., Anguita J., Juncadella I., Nickoloff B.J., Le Poole I.C., et al. Notch signaling regulates mouse and human Th17 differentiation. J.Immunol. 2011, 187:692-701.
24. Kelly A.P., Finlay D.K., Hinton H.J., Clarke R.G., Fiorini E., Radtke F., Cantrell D.A. Notch-induced Tcell development requires phosphoinositide-dependent kinase 1. EMBO J. 2007, 26:3441-3450.
25. Khwaja S.S., Liu H., Tong C., Jin F., Pear W.S., van Deursen J., Bram R.J. HIV-1 Rev-binding protein accelerates cellular uptake of iron to drive Notch-induced Tcell leukemogenesis in mice. J.Clin. Invest. 2010, 120:2537-2548.
26. Kontermann R.E. Dual targeting strategies with bispecific antibodies. MAbs 2012, 4:182-197.
27. Lanzavecchia A., Iezzi G., Viola A. From TCR engagement to Tcell activation: a kinetic view of Tcell behavior. Cell 1999, 96:1-4.
28. Lenardo M.J. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 1991, 353:858-861.
29. Liao W., Lin J.X., Leonard W.J. Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity 2013, 38:13-25.
30. Lucas B., Germain R.N. Opening a window on thymic positive selection: developmental changes in the influence of cosignaling by integrins and CD28 on selection events induced by TCR engagement. J.Immunol. 2000, 165:1889-1895.
31. MacIver N.J., Michalek R.D., Rathmell J.C. Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 2013, 31:259-283.
32. McCubrey J.A., Steelman L.S., Bertrand F.E., Davis N.M., Sokolosky M., Abrams S.L., Montalto G., D'Assoro A.B., Libra M., Nicoletti F., et al. GSK-3 as potential target for therapeutic intervention in cancer. Oncotarget 2014, 5:2881-2911.
33. Minter L.M., Osborne B.A. Canonical and non-canonical notch signaling in CD4+ Tcells. Notch Regulation of the Immune System 2012, 99-114. Berlin Heidelberg: Springer. F. Radtke (Ed.).
34. Minter L.M., Turley D.M., Das P., Shin H.M., Joshi I., Lawlor R.G., Cho O.H., Palaga T., Gottipati S., Telfer J.C., et al. Inhibitors of gamma-secretase block invivo and invitro T helper type 1 polarization by preventing Notch upregulation of Tbx21. Nat. Immunol. 2005, 6:680-688.
35. Mukherjee S., Schaller M.A., Neupane R., Kunkel S.L., Lukacs N.W. Regulation of Tcell activation by Notch ligand, DLL4, promotes IL-17 production and Rorc activation. J.Immunol. 2009, 182:7381-7388.
36. Naramura M., Hu R.J., Gu H. Mice with a fluorescent marker for interleukin 2 gene activation. Immunity 1998, 9:209-216.
37. Nurieva R.I., Chuvpilo S., Wieder E.D., Elkon K.B., Locksley R., Serfling E., Dong C. A costimulation-initiated signaling pathway regulates NFATc1 transcription in T lymphocytes. J.Immunol. 2007, 179:1096-1103.
38. O'Donnell K.A., Yu D., Zeller K.I., Kim J.-W., Racke F., Thomas-Tikhonenko A., Dang C.V. Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis. Mol. Cell. Biol. 2006, 26:2373-2386.
39. Ohteki T., Parsons M., Zakarian A., Jones R.G., Nguyen L.T., Woodgett J.R., Ohashi P.S. Negative regulation of Tcell proliferation and interleukin 2 production by the serine threonine kinase GSK-3. J.Exp. Med. 2000, 192:99-104.
40. Ong C.T., Sedy J.R., Murphy K.M., Kopan R. Notch and presenilin regulate cellular expansion and cytokine secretion but cannot instruct Th1/Th2 fate acquisition. PLoS ONE 2008, 3:e2823.
41. Palomero T., Sulis M.L., Cortina M., Real P.J., Barnes K., Ciofani M., Caparros E., Buteau J., Brown K., Perkins S.L., et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat. Med. 2007, 13:1203-1210.
42. Pellegrinet L., Rodilla V., Liu Z., Chen S., Koch U., Espinosa L., Kaestner K.H., Kopan R., Lewis J., Radtke F. Dll1- and dll4-mediated notch signaling are required for homeostasis of intestinal stem cells. Gastroenterology 2011, 140:1230-1240. e1-e7.
43. Perez-Diez A., Joncker N.T., Choi K., Chan W.F., Anderson C.C., Lantz O., Matzinger P. CD4 cells can be more efficient at tumor rejection than CD8 cells. Blood 2007, 109:5346-5354.
44. Pollizzi K.N., Powell J.D. Integrating canonical and metabolic signalling programmes in the regulation of Tcell responses. Nat. Rev. Immunol. 2014, 14:435-446.
45. Radtke F., MacDonald H.R., Tacchini-Cottier F. Regulation of innate and adaptive immunity by Notch. Nat. Rev. Immunol. 2013, 13:427-437.
46. Riha P., Rudd C.E. CD28 co-signaling in the adaptive immune response. Self Nonself 2010, 1:231-240.
47. Rothenberg E.V., Ward S.B. A dynamic assembly of diverse transcription factors integrates activation and cell-type information for interleukin 2 gene regulation. Proc. Natl. Acad. Sci. USA 1996, 93:9358-9365.
48. Samon J.B., Champhekar A., Minter L.M., Telfer J.C., Miele L., Fauq A., Das P., Golde T.E., Osborne B.A. Notch1 and TGFbeta1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory Tcells. Blood 2008, 112:1813-1821.
49. Shin H.M., Minter L.M., Cho O.H., Gottipati S., Fauq A.H., Golde T.E., Sonenshein G.E., Osborne B.A. Notch1 augments NF-kappaB activity by facilitating its nuclear retention. EMBO J. 2006, 25:129-138.
50. Takeichi N., Yanagisawa S., Kaneyama T., Yagita H., Jin Y.H., Kim B.S., Koh C.S. Ameliorating effects of anti-Dll4 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease. Int. Immunol. 2010, 22:729-738.
51. Tanigaki K., Tsuji M., Yamamoto N., Han H., Tsukada J., Inoue H., Kubo M., Honjo T. Regulation of alphabeta/gammadelta Tcell lineage commitment and peripheral Tcell responses by Notch/RBP-J signaling. Immunity 2004, 20:611-622.
52. Teh H.S., Teh S.J. High concentrations of antigenic ligand activate and do not tolerize naive CD4 Tcells in the absence of CD28/B7 costimulation. Cell. Immunol. 1997, 179:74-83.
53. Tran I.T., Sandy A.R., Carulli A.J., Ebens C., Chung J., Shan G.T., Radojcic V., Friedman A., Gridley T., Shelton A., et al. Blockade of individual Notch ligands and receptors controls graft-versus-host disease. J.Clin. Invest. 2013, 123:1590-1604.
54. Wang H., Zang C., Taing L., Arnett K.L., Wong Y.J., Pear W.S., Blacklow S.C., Liu X.S., Aster J.C. NOTCH1-RBPJ complexes drive target gene expression through dynamic interactions with superenhancers. Proc. Natl. Acad. Sci. USA 2014, 111:705-710.
55. Weber J., Atkins M., Hwu P., Radvanyi L., Sznol M., Yee C. White paper on adoptive cell therapy for cancer with tumor-infiltrating lymphocytes: a report of the CTEP subcommittee on adoptive cell therapy. Clin. Cancer Res. 2011, 17:1664-1673. Immunotherapy Task Force of the NCI Investigational Drug Steering Committee.
56. Wells A.D., Gudmundsdottir H., Turka L.A. Following the fate of individual Tcells throughout activation and clonal expansion. Signals from Tcell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J.Clin. Invest. 1997, 100:3173-3183.
57. Yan M., Callahan C.A., Beyer J.C., Allamneni K.P., Zhang G., Ridgway J.B., Niessen K., Plowman G.D. Chronic DLL4 blockade induces vascular neoplasms. Nature 2010, 463:E6-E7.